Serious Mental Illness at AAAP 37th Annual Meeting and Scientific Symposium

7 sessions on serious mental illness · November 12–15, 2026, Memphis, TN. Compare serious mental illness at other meetings →

Thursday, November 12

Friday, November 13

  • 15:30–17:00 · Oral abstract

    Long-Acting Injectable Antipsychotics in Serious Mental Illness with Co-Occurring Substance Use: A Retrospective Cohort Study

    Kathryn Renard

    Cohort study of long-acting injectable antipsychotic use in patients with serious mental illness and substance use.

    Long-Acting Injectables · Substance Use Disorders

  • 15:30–17:00 · Oral abstract

    Serious Mental Illness and Outcomes in Inpatient Detoxification and Rehabilitation: A Retrospective Cohort Study

    Sean Lynch

    Cohort study of how serious mental illness affects inpatient detoxification and rehabilitation outcomes.

    Substance Use Disorders

Sunday, November 15

Posters (2)

  • Associations between Cumulative Adversity and Quality of Life: The Roles of Substance Use and Post-Traumatic Stress among People Experiencing Homelessness — Ethan Faries
  • Single and multiple tobacco product use among people with mental illness and substance use disorders: Findings from the National Surveys on Drug Use and Health, 2022-2024 — Kelly Peck

Schedule to be announced

Other topics at this meeting

Substance Use Disorders 87Opioid Use Disorder 48Cannabis & Cannabinoids 17Alcohol Use Disorder 16Child & Adolescent 14Drug Interactions & Safety 13Education & Training 12Schizophrenia & Psychosis 12Emergency & Acute Psychiatry 11Digital Psychiatry & AI 8Practice, Policy & Workforce 8PTSD & Trauma 8

Full program overview →